Quick Answer
Melissa Sleep Quality Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Elevated or blunted cortisol levels have been associated with impaired sleep quality, heightened emotional distress, and reduced mental well-being in both clinical populations and non-clinical models (,,).
Key Takeaways
- 01Elevated or blunted cortisol levels have been associated with impaired sleep quality, heightened emotional distress, and reduced mental well-being in both clinical populations and non-clinical models (,,). [Mazzola Giuseppe (2026)]
- 02Experimental models suggest that rosmarinic acid, the main bioactive compound of, can reduce stress-induced corticosterone elevations, which may translate into improved sleep architecture and psychological outcomes (,). [Mazzola Giuseppe (2026)]
- 0314 16 16 17 In a recent clinical study, 3 weeks of daily supplementation with Melissa extract formulated in phospholipids (Melissa Phytosome™, as Relissa™) was associated with significant improvements in sleep quality, depression, stress, affective states, and quality of life in adults with emotional distress at the daily dose of 400 mg (–). [Mazzola Giuseppe (2026)]
- 041 5 1 2 6 Dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis, as reflected by altered diurnal cortisol secretion, is strongly implicated in the pathophysiology of sleep disturbances, mood disorders, and stress-related conditions (–). [Mazzola Giuseppe (2026)]
The current Migaku evidence database contains 2 reusable source documents for Melissa Sleep Quality Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Elevated or blunted cortisol levels have been associated with impaired sleep quality, heightened emotional distress, and reduced mental well-being in both clinical populations and non-clinical models (,,). [Mazzola Giuseppe (2026); evidence level 4]
- Experimental models suggest that rosmarinic acid, the main bioactive compound of, can reduce stress-induced corticosterone elevations, which may translate into improved sleep architecture and psychological outcomes (,). [Mazzola Giuseppe (2026); evidence level 4]
- 14 16 16 17 In a recent clinical study, 3 weeks of daily supplementation with Melissa extract formulated in phospholipids (Melissa Phytosome™, as Relissa™) was associated with significant improvements in sleep quality, depression, stress, affective states, and quality of life in adults with emotional distress at the daily dose of 400 mg (–). [Mazzola Giuseppe (2026); evidence level 4]
- 1 5 1 2 6 Dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis, as reflected by altered diurnal cortisol secretion, is strongly implicated in the pathophysiology of sleep disturbances, mood disorders, and stress-related conditions (–). [Mazzola Giuseppe (2026); evidence level 4]
- Historical use of medicinal plants was a result of cumulative trial and error experience and the transmission of traditional knowledge between generations, which later inspired systematic efforts to turn empirical claims into evidence-based arguments []. [Cîmpeanu Ioan-Alexandru (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources
- Salivary cortisol dynamics and their relationship with sleep and mental well-being in adults receiving a phospholipid-based Melissa officinalis supplement: a secondary analysis in a subpopulation
- Melissa officinalis L. (Lemon Balm): An Integrative Review of Phytochemistry and Evidence from Preclinical Research to Clinical Studies